Formosa Laboratories, Inc. (TPE:4746)
Taiwan · Delayed Price · Currency is TWD 45.55
-0.85 (-1.83%)
Sep 8, 2026, 1:30 PM CST
Formosa Laboratories Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 4,640 | 4,851 | 4,731 | 4,360 | 3,766 | 3,142 |
Revenue Growth | -2.71% | 2.54% | 8.50% | 15.80% | 19.83% | 2.18% |
Gross Profit Gross Profit Growth | 1,925 | 2,032 | 2,049 | 1,923 | 1,390 | 971.44 |
Operating Income Operating Income Growth | 670.24 | 803.18 | 725.9 | 674.98 | 163.49 | -168.02 |
Net Income Net Income Growth | 475.7 | 441.11 | 157.27 | 126.24 | 409.36 | 1,249 |
Earnings Per Share EPS Growth | 4.17 | 3.64 | 1.30 | 1.05 | 3.39 | 10.32 |
EPS Growth | - | 180.00% | 23.84% | -69.03% | -67.14% | 198.32% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Active Pharmaceutical Ingredients(API) Active Pharmaceutical Ingredients(API) Growth | 4,601 | 4,842 | 4,605 | 4,346 | 3,804 | 3,169 |
Other Operating Departments Other Operating Departments Growth | 63.06 | 16.96 | 153.36 | 31.17 | 1.32 | 28.53 |
Write-Off Due to Consolidation Write-Off Due to Consolidation Growth | -24.21 | -7.35 | -27.5 | -17.02 | -39.96 | -55.15 |
Total Total Growth | 4,640 | 4,851 | 4,731 | 4,360 | 3,766 | 3,142 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 2,070 | 2,494 | 2,703 | 2,510 | 1,631 | 1,093 |
Total Debt Total Debt Growth | 3,694 | 3,610 | 3,899 | 4,063 | 3,800 | 3,420 |
Net Cash (Debt) Net Cash Growth | -1,624 | -1,115 | -1,196 | -1,553 | -2,169 | -2,327 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -14.24 | -9.20 | -9.88 | -12.89 | -17.95 | -19.15 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 821.58 | 1,315 | 726.33 | 826.6 | 643.09 | 311.16 |
Capital Expenditures CapEx Growth | -1,172 | -797.08 | -585.95 | -538.53 | -438.43 | -508.78 |
Free Cash Flow Free Cash Flow Growth | -350.81 | 518.17 | 140.38 | 288.07 | 204.66 | -197.62 |
Free Cash Flow Growth | - | 269.12% | -51.27% | 40.76% | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 41.49% | 41.89% | 43.30% | 44.11% | 36.92% | 30.91% |
Operating Margin | 14.45% | 16.56% | 15.34% | 15.48% | 4.34% | -5.35% |
Pretax Margin | 10.77% | 10.34% | 4.19% | 3.27% | 8.85% | 34.61% |
Profit Margin | 10.25% | 9.09% | 3.32% | 2.90% | 10.87% | 39.75% |
FCF Margin | -7.56% | 10.68% | 2.97% | 6.61% | 5.44% | -6.29% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 3.000 | 3.000 | 3.000 | 2.000 | 1.000 | 2.000 |
Dividend Per Share Growth | 0% | 0% | 50.00% | 100.00% | -50.00% | - |
Dividend Yield | 6.52% | 5.36% | 4.84% | 2.22% | 1.56% | 3.95% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 11.63 | 16.17 | 52.61 | 97.16 | 21.59 | 5.83 |
Forward PE | - | 9.70 | 10.94 | 13.33 | 25.71 | 16.30 |
P/FCF Ratio | - | 13.76 | 58.94 | 42.58 | 43.19 | - |
PS Ratio | 1.18 | 1.47 | 1.75 | 2.81 | 2.35 | 2.32 |